GE HealthCare Technologies Operating Income 2020-2024 | GEHC
GE HealthCare Technologies annual/quarterly operating income history and growth rate from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- GE HealthCare Technologies operating income for the quarter ending March 31, 2024 was $0.539B, a 3.58% decline year-over-year.
- GE HealthCare Technologies operating income for the twelve months ending March 31, 2024 was $2.415B, a 6.1% decline year-over-year.
- GE HealthCare Technologies annual operating income for 2023 was $2.435B, a 3.45% decline from 2022.
- GE HealthCare Technologies annual operating income for 2022 was $2.522B, a 9.77% decline from 2021.
- GE HealthCare Technologies annual operating income for 2021 was $2.795B, a 2.76% increase from 2020.
| GE HealthCare Technologies Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $2,435 |
| 2022 | $2,522 |
| 2021 | $2,795 |
| 2020 | $2,720 |
| 2019 | $2,124 |
| GE HealthCare Technologies Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $539 |
| 2023-12-31 | $689 |
| 2023-09-30 | $617 |
| 2023-06-30 | $570 |
| 2023-03-31 | $559 |
| 2022-12-31 | $777 |
| 2022-09-30 | $605 |
| 2022-06-30 | $631 |
| 2022-03-31 | $509 |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $35.723B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $7.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.477B | 0.00 |
| Axonics (AXNX) | United States | $3.412B | 0.00 |
| 10x Genomics (TXG) | United States | $3.208B | 0.00 |
| Enovis (ENOV) | United States | $3.038B | 23.08 |
| Azenta (AZTA) | United States | $2.905B | 236.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.820B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.680B | 0.00 |
| Privia Health (PRVA) | United States | $2.139B | 94.89 |
| Schrodinger (SDGR) | United States | $1.827B | 0.00 |
| Omnicell (OMCL) | United States | $1.248B | 30.53 |
| Phreesia (PHR) | United States | $1.185B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.821B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.680B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.619B | 0.00 |
| Talkspace (TALK) | United States | $0.536B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.373B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.318B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.183B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.164B | 0.00 |
| American Well (AMWL) | United States | $0.154B | 0.00 |
| Outset Medical (OM) | United States | $0.147B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
| Augmedix (AUGX) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.04 |
| 111 (YI) | China | $0.088B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.048B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |